.svg)
At identifeye HEALTH, we are developing prediction models that leverage the intersection of multiple retinal imaging modalities with expert annotations to create comprehensive and non-invasive health assessments.
We are part of 4Catalyzer, a health technology incubator founded by Dr. Jonathan Rothberg and dedicated to making a global impact through bold innovations in medicine, engineering, machine learning, life sciences, and biotech.
4Catalyzer companies have been named Technology Pioneers three times by the World Economic Forum and top innovations of the year twice by peer-reviewed academic journal Science Magazine. 4Catalyzer has raised over $2 billion in funding and taken three of its eight companies — Butterfly Network, Hyperfine, and Quantum-Si—public.
As a 4Catalyzer company, our guiding philosophy is to build on three pillars that form a virtuous circle: state of the art silicon devices, cloud-based data management, and deep learning.
Dr. Jonathan Rothberg, a serial entrepreneur, has founded and invented and brought to market massively parallel DNA sequencing, semiconductor sequencing, and ultrasound-on-a-chip; he was awarded the National Medal of Technology and Innovation by Barack Obama.
The use of image analytics tools developed by the tech industry is becoming more widespread in the healthcare space. By peering into the eye with a camera and an algorithm, recent studies and advances in AI have enabled accurate prediction of numerous conditions, such as neurological and cardiovascular risk.
As a 4Catalyzer company, our guiding philosophy is to build on three pillars that form a virtuous circle: state of the art silicon devices, cloud-based data management, and deep learning.
The retina, the light-sensitive tissue layer of the eye, is the only place in the human body where arteries, veins, capillaries, and nerves can be seen directly. Our mission is to use this wealth of information in the human eye to democratize healthcare and improve lives.
Through different imaging technologies, a novel chemical sensor and proprietary algorithms, the Tesseract device is uniquely positioned to extract information from the retina non-invasively and generate accurate predictions and diagnoses of multiple health conditions from retinal scans to improve patient care.
